ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1334

Assessing the Performance of Validated Frailty Instruments in Veterans with Rheumatoid Arthritis (RA)

Kylie Riggles1, Hannah Brubeck2, Riley Bass3, Courtney Loecker4, Punyasha Roul5, Bryant England6, Elizabeth Wahl7, James Andrews8, Namrata Singh9, Joshua Baker10, Patti Katz11, Dolores Shoback12, Jose Garcia13, ariela orkaby14 and Katherine Wysham15, 1VA Puget Sound Health Care System, Bellevue, WA, 2VA Puget Sound Health Care System, Seattle, WA, 3VA Puget Sound Health Care System, Gig Harbor, WA, 4University of Nebraska, Lincoln, NE, 5UNMC, Omaha, NE, 6University of Nebraska Medical Center, Omaha, NE, 7VA Puget Sound Healthcare System, Seattle, WA, 8University of Alabama at Birmingham, Birmingham, AL, 9University of Washington, Bellevue, WA, 10University of Pennsylvania, Philadelphia, PA, 11UCSF, San Rafael, CA, 12San Francisco VA/University of California, San Francisco, San Francisco, CA, 13VA Puget Sound Health Care System/University of Washington, Seattle, WA, 14New England VA Geriatric Research Education and Clinical Center/Boston VA/Division of Aging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 15VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA

Meeting: ACR Convergence 2024

Keywords: Cohort Study, Patient reported outcomes, rheumatoid arthritis, risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Frailty is a state of decreased physiological reserve that confers an increased vulnerability to stressors and adverse outcomes1. Compared to the general population, frailty occurs at a younger age in RA2, and the prevalence of frailty is higher in Veteran populations3. Fried Frailty Phenotype (FFP)1, FRAIL Scale (FRAIL)4, and VA Frailty Index (VAFI)3 are validated tools that use either a phenotype (FFP, FRAIL) or deficit accumulation approach (VAFI). Each has been studied in RA; however, they have not all been measured in a single RA cohort. This study aims to compare the agreement of these three frailty instruments.

Methods: Data were from the VA Rheumatoid Arthritis Frailty and Osteoporosis (VA-FROst) single center longitudinal cohort. Participants met the 2010 ACR RA classification criteria and were ³35 years old. FFP measured fatigue, physical activity, weight loss, hand grip strength (HGS) and walking speed1. FRAIL queried patient-reported fatigue, ability to climb stairs, walk moderate distances, presence of ³5 illness, and weight loss4. VAFI used electronic health record (EHR) diagnostic codes to inform 31 deficit categories based on morbidities, cognition/mood, sensory and functional impairments, and other/geriatric syndromes3. The VAFI is a ratio of the number of deficits divided by the total. Each frailty instrument categorized individuals as robust, pre-frail or frail1,3,4. We examined subcomponents contributing to each frailty instrument. Percent agreement and kappa tests evaluated accordance between instruments.

Results: We studied 116 Veterans aged 63.9±11.5, 84 (72%) participants were male, and 13 (11%) were Black (Table 1). Disease duration was 13.8±12.8 years, anti-CCP positivity was present in 76 (66%), and disease activity was moderate on average (DAS28ESR 3.7±1.5). Compared to the other instruments, VAFI categorized the most participants as frail (n=42, 36%), followed by FRAIL (n=24, 21%), and FFP (n=9, 8%) (Figure 1). Exhaustion (47%) and low HGS (40%) were the most common FFP deficits (Table 2). All FRAIL subcomponents had similar frequencies (26-32%) with exception of ≥5 illnesses (7%). VAFI score was primarily driven by morbidities (42%) and functional deficits (30%). One (1%) Veteran was frail by all instruments, 17 (15%) were frail by 2 instruments. The frailty instruments demonstrated moderate percent agreement (58%-75%) and poor agreement by kappa testing (k 0.04-0.14) (Figure 1).

Conclusion: In our cohort of Veterans with RA, measuring frailty by the FFP, FRAIL, and VAFI showed low agreement by kappa testing. This incongruence is likely due to differences in the way frailty is conceptualized (phenotype vs. deficit accumulation) and assessed (patient-report, direct assessment, EHR). Further studies comparing the predictive capacity of long-term health outcomes between frailty instruments are needed to better understand these differences.

  1. Fried L et al. J Gerontol A Biol Sci Med Sci 2001
  2. Loecker C et al. ACR Open 2023
  3. Orkaby AR et al. J Gerontol A Biol Sci Med Sci 2019
  4. Van Kan GA et al. J Am Med Dir Assoc 2008

Supporting image 1

Table 1. Baseline demographics and clinical characteristics (N=116).

Supporting image 2

Table 2. Individual frailty subcomponent frequencies or percent contribution for the Fried Frailty Phenotype, the FRAIL scale, and the VA Frailty Index (N=116).

Supporting image 3

Figure 1. Overlapping categorization of Veterans measured as frail or non-frail by each frailty instrument (Fried Frailty Phenotype (FFP), Veteran’s Affairs Frailty Index (VAFI), and FRAIL scale (FRAIL)). Percent agreements and kappa testing were calculated between frail groups (N=116).


Disclosures: K. Riggles: None; H. Brubeck: None; R. Bass: None; C. Loecker: None; P. Roul: None; B. England: Boehringer-Ingelheim, 5; E. Wahl: None; J. Andrews: None; N. Singh: None; J. Baker: Cumberland Pharma, 2, Formation Bio, 2, Horizon, 5; P. Katz: None; D. Shoback: None; J. Garcia: None; a. orkaby: None; K. Wysham: None.

To cite this abstract in AMA style:

Riggles K, Brubeck H, Bass R, Loecker C, Roul P, England B, Wahl E, Andrews J, Singh N, Baker J, Katz P, Shoback D, Garcia J, orkaby a, Wysham K. Assessing the Performance of Validated Frailty Instruments in Veterans with Rheumatoid Arthritis (RA) [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/assessing-the-performance-of-validated-frailty-instruments-in-veterans-with-rheumatoid-arthritis-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-the-performance-of-validated-frailty-instruments-in-veterans-with-rheumatoid-arthritis-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology